China's Law on Maternal and Infant Health Care regulates genetic disease diagnosis and pre-natal diagnosis. Under this law, PND is explicitly permitted but sex identification of the fetus by technical means is forbidden unless it is positively necessary on medical grounds. PND is indicated when the physician detects or suspects an abnormality with the fetus. In addition, all medical and health institutions (and their personnel) carrying out genetic diagnosis and PND must meet requirements and technical standards set out by the administrative department of public health authority. Failure to comply with the law will result in administrative sanctions.

The Ministry of Health, under their regulations and guiding principles on human assisted reproductive technologies, has also banned sex selection for non-medical purposes, as well as the commercial use of gametes, zygotes, and embryos.

Further reference:

• Law on Maternal and Infant Health Care (adopted at the Tenth Meeting of the Standing Committee of the Eighth National People’s Congress, October 27, 1994 – effective as of June 1, 1995).
  
  
• Ministry of Health, Ethical Principles of Human Assisted Reproductive Technologies, 14:1 Eubios Journal of Asian and International Bioethics 8 (January 2004).
  
  
• Ministry of Health, Regulation on Human Assisted Reproductive Technologies (2001), 14:1 Eubios Journal of Asian and International Bioethics 8 (January 2004).